Table 2 Univariate and multivariate Cox regression analyses for overall survival of gastric cancer patients.
Predictor | Univariate Analysis | Multivariate Analysis | ||
|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | |
Age, years | ||||
≥65 vs <65 | 1.546 (1.014–2.359) | 0.043* | ||
Gender | ||||
Female vs Male | 1.458 (0.953–2.230) | 0.082 | ||
Size, cm | ||||
>4 cm vs ≤4 cm | 2.055 (1.267–3.335) | 0.004* | 1.770 (1.089–2.876) | 0.021* |
Tumour location | ||||
Middle 1/3 vs Upper 1/3 | 0.966 (0.463–2.016) | 0.926 | ||
Lower 1/3 vs Upper 1/3 | 0.781 (0.449–1.360) | 0.382 | ||
More than 2/3 stomach vs Upper 1/3 | 0.984 (0.525–1.843) | 0.959 | ||
pTNM classification | ||||
II vs I | 1.584 (0.206–12.201) | 0.659 | ||
III vs I | 3.791 (0.522–27.541) | 0.188 | ||
Depth of invasion | ||||
T4 vs T2–T3 | 0.999 (0.532–1.879) | 0.999 | ||
Lymph node metastasis (pN stage) | ||||
N1–N3 vs N0 | 2.596 (1.376–4.895) | 0.003** | 2.083 (1.093–3.971) | 0.026* |
Lauren type | ||||
Diffuse vs Intestinal | 1.371 (0.837–2.247) | 0.211 | ||
Expression of ACAT2 | ||||
High vs Low | 2.932 (1.508–5.701) | 0.002** | 2.003 (1.010–3.970) | 0.047* |
